378 related articles for article (PubMed ID: 19787766)
21. Prognostic groups in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy.
Eriksen MT; Wibe A; Haffner J; Wiig JN;
Dis Colon Rectum; 2007 Feb; 50(2):156-67. PubMed ID: 17180256
[TBL] [Abstract][Full Text] [Related]
22. Curative potential of multimodality therapy for locally recurrent rectal cancer.
Hahnloser D; Nelson H; Gunderson LL; Hassan I; Haddock MG; O'Connell MJ; Cha S; Sargent DJ; Horgan A
Ann Surg; 2003 Apr; 237(4):502-8. PubMed ID: 12677146
[TBL] [Abstract][Full Text] [Related]
23. Transanal excision vs. major surgery for T1 rectal cancer.
Endreseth BH; Myrvold HE; Romundstad P; Hestvik UE; Bjerkeset T; Wibe A;
Dis Colon Rectum; 2005 Jul; 48(7):1380-8. PubMed ID: 15906120
[TBL] [Abstract][Full Text] [Related]
24. Effect of hospital caseload on long-term outcome after standardization of rectal cancer surgery at a national level.
Wibe A; Eriksen MT; Syse A; Tretli S; Myrvold HE; Søreide O;
Br J Surg; 2005 Feb; 92(2):217-24. PubMed ID: 15584060
[TBL] [Abstract][Full Text] [Related]
25. Local recurrence after curative resection for rectal cancer is associated with anterior position of the tumour.
Chan CL; Bokey EL; Chapuis PH; Renwick AA; Dent OF
Br J Surg; 2006 Jan; 93(1):105-12. PubMed ID: 16302179
[TBL] [Abstract][Full Text] [Related]
26. Changing strategy for rectal cancer is associated with improved outcome.
Dahlberg M; Glimelius B; Påhlman L
Br J Surg; 1999 Mar; 86(3):379-84. PubMed ID: 10201783
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience.
Valentini V; Coco C; Rizzo G; Manno A; Crucitti A; Mattana C; Ratto C; Verbo A; Vecchio FM; Barbaro B; Gambacorta MA; Montoro C; Barba MC; Sofo L; Papa V; Menghi R; D'Ugo DM; Doglietto G
Surgery; 2009 May; 145(5):486-94. PubMed ID: 19375606
[TBL] [Abstract][Full Text] [Related]
28. Intraoperative radiation therapy (IORT) in primary locally advanced and recurrent carcinoma of the rectum at a "non-dedicated" facility.
Hesselmann S; Micke O; Bruewer M; Ochman S; Senninger N; Willich N; Schaefer U
Anticancer Res; 2003; 23(2C):1875-81. PubMed ID: 12820472
[TBL] [Abstract][Full Text] [Related]
29. Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer.
Yamada K; Ishizawa T; Niwa K; Chuman Y; Akiba S; Aikou T
Br J Surg; 2001 Jul; 88(7):988-93. PubMed ID: 11442533
[TBL] [Abstract][Full Text] [Related]
30. Treatment strategy for locally recurrent rectal cancer.
Moriya Y
Jpn J Clin Oncol; 2006 Mar; 36(3):127-31. PubMed ID: 16598032
[TBL] [Abstract][Full Text] [Related]
31. Hydronephrosis as a prognostic factor in pelvic recurrence from rectal and colon carcinomas.
Larsen SG; Wiig JN; Giercksky KE
Am J Surg; 2005 Jul; 190(1):55-60. PubMed ID: 15972173
[TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics and outcomes in patients with advanced rectal cancer: a national prospective cohort study.
Sigurdsson HK; Körner H; Dahl O; Skarstein A; Søreide JA;
Dis Colon Rectum; 2007 Mar; 50(3):285-91. PubMed ID: 17235720
[TBL] [Abstract][Full Text] [Related]
33. The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer.
Martling A; Cedermark B; Johansson H; Rutqvist LE; Holm T
Br J Surg; 2002 Aug; 89(8):1008-13. PubMed ID: 12153626
[TBL] [Abstract][Full Text] [Related]
34. Population-based study of local surgery for rectal cancer.
Folkesson J; Johansson R; Påhlman L; Gunnarsson U
Br J Surg; 2007 Nov; 94(11):1421-6. PubMed ID: 17661311
[TBL] [Abstract][Full Text] [Related]
35. Value of intraoperative radiotherapy in locally advanced rectal cancer.
Ferenschild FT; Vermaas M; Nuyttens JJ; Graveland WJ; Marinelli AW; van der Sijp JR; Wiggers T; Verhoef C; Eggermont AM; de Wilt JH
Dis Colon Rectum; 2006 Sep; 49(9):1257-65. PubMed ID: 16912909
[TBL] [Abstract][Full Text] [Related]
36. Intraarterial 5-FU-infusion and simultaneous radiotherapy as palliative treatment of recurrent rectal cancer.
Schnabel T; Zamboglou N; Kuhn FP; Kolotas C; Schmitt G
Strahlenther Onkol; 1992 Oct; 168(10):584-7. PubMed ID: 1279822
[TBL] [Abstract][Full Text] [Related]
37. Potentially curative resection for locoregional recurrence of colorectal cancer.
Fuzun M; Terzi C; Sokmen S; Unek T; Haciyanli M
Surg Today; 2004; 34(11):907-12. PubMed ID: 15526124
[TBL] [Abstract][Full Text] [Related]
38. Intraoperative radiotherapy for locally recurrent rectal cancer in The Netherlands.
Rutten HJ; Mannaerts GH; Martijn H; Wiggers T
Eur J Surg Oncol; 2000 Nov; 26 Suppl A():S16-20. PubMed ID: 11130874
[TBL] [Abstract][Full Text] [Related]
39. Impact of a surgical training programme on rectal cancer outcomes in Stockholm.
Martling A; Holm T; Rutqvist LE; Johansson H; Moran BJ; Heald RJ; Cedermark B
Br J Surg; 2005 Feb; 92(2):225-9. PubMed ID: 15609382
[TBL] [Abstract][Full Text] [Related]
40. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
